Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Rheumaplex is a traditional herbal medicinal product (THR) primarily used for the symptomatic relief of rheumatic pain, backache, and muscular aches. The formulation typically combines three key botanical extracts: Devil's Claw (Harpagophytum procumbens), White Willow bark (Salix alba), and Feverfew (Tanacetum parthenium). The therapeutic effects are attributed to the synergistic action of its constituents, notably iridoid glycosides (such as harpagoside) and salicylates (such as salicin). Harpagoside is known to inhibit the production of pro-inflammatory mediators by targeting the cyclooxygenase (COX) and lipoxygenase (LOX) pathways, while salicin acts as a natural precursor to salicylic acid, providing analgesic and anti-inflammatory effects through non-selective COX inhibition. Rheumaplex is marketed as a natural alternative for the management of chronic musculoskeletal conditions and is regulated as a traditional herbal medicine in jurisdictions like the United Kingdom.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Rheumaplex.